Latest Lung cancer staging Stories
AMSTERDAM and PHOENIX, July 4, 2011 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED(TM) test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.
The National Lung Screening Trial (NLST) is the first scientific study that provides clear evidence that CT screening significantly reduces the death rate due to lung cancer.
Researchers have identified characteristic patterns of molecules called microRNA (miRNA) in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.
MINNEAPOLIS, April 4, 2011 /PRNewswire/ -- superDimension, Ltd. Â®, a privately-owned company that develops minimally invasive interventional pulmonology devices, today announced it has received FDA 510(k) clearance for the superDimension marker delivery kit.
Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases.
A study released Tuesday by the Journal of the American Medical Association (JAMA) leaves researchers with evidence that early stage breast cancer patients who have a small amount of lymph node removed fare as well as those who get more extensive surgery.
With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.
A comparison of two strategies to determine the stage of suspected non-small cell lung cancer (NSCLC) finds that the less invasive method is more effective at identifying a type of lung cancer that has spread, and may result in a reduction of unnecessary surgical procedures and associated adverse effects for certain patients.
Twenty percent fewer lung cancer deaths seen among those screened with CT than with chest X-ray in a trial conducted by the American College of Radiology Imaging Network and the Lung Screening Study group. PHILADELPHIA, Nov.
A study in the New England Journal of Medicine shows more than half of patients with a specific kind of lung cancer are responding positively to a treatment that targets the gene that drives their cancer.
- Large; stout; burly.